NYSE: FSK

FS KKR Capital Corp

CIK 0001422183

Mega by assets Assets $12.0B as of Sep 13, 2026

Every 8-K is open in full. Other 10-Ks and 10-Qs show a 3-bullet preview. A free account reads 3 more full reports a month. Generating a report requires a verified account.

Sign up free

Want to see a complete report first? Today's free report (LAC 10-Q) is open in full — no account needed.

8-K Filed Aug 20, 2026 · Period ending Aug 20, 2026

Summary not yet generated.

8-K Filed Aug 13, 2026 · Period ending Aug 13, 2026

FSK posts investor presentations to website under Regulation FD

1 material change detected. Sign up free to read the summary.

Partner

Trade FSK commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Aug 6, 2026 · Period ending Aug 6, 2026

Summary not yet generated.

10-Q Filed Aug 6, 2026 · Period ending Jun 30, 2026 Red flag

FSK net loss narrows 84% to -$34.0M as portfolio shrinks; four lawsuits filed

4 material changes detected. Sign up free to read the summary.

8-K Filed Jul 9, 2026 · Period ending Jul 9, 2026

Summary not yet generated.

8-K Filed Jun 29, 2026 · Period ending Jun 29, 2026

Summary not yet generated.

8-K Filed Jun 18, 2026 · Period ending Jun 18, 2026

Summary not yet generated.

8-K Filed Jun 8, 2026 · Period ending Jun 8, 2026

Summary not yet generated.

8-K Filed Jun 3, 2026 · Period ending Jun 1, 2026

Summary not yet generated.

10-Q Filed May 11, 2026 · Period ending Mar 31, 2026

Summary not yet generated.

10-K Filed Feb 25, 2026 · Period ending Dec 31, 2025

Summary not yet generated.

10-Q Filed Nov 5, 2025 · Period ending Sep 30, 2025

Summary not yet generated.

10-Q Filed Aug 6, 2025 · Period ending Jun 30, 2025

Summary not yet generated.

10-K Filed Feb 26, 2025 · Period ending Dec 31, 2024

Summary not yet generated.

10-K/A Filed Apr 30, 2021 · Period ending Dec 31, 2020

Summary not yet generated.

424B3 Filed Mar 1, 2021

Summary not yet generated.

Latest financial statements

From 10-Q filed Aug 6, 2026 (period ending Jun 30, 2026). As printed on the EDGAR/iXBRL face — not generated by the model.

As filed

Consolidated Statements of Operations (Unaudited)

Description Three months ended June 30, 2026 Three months ended June 30, 2025 Six months ended June 30, 2026 Six months ended June 30, 2025
Investment income
From non-controlled/unaffiliated investments:
Interest income 166 224 343 441
Paid-in-kind interest income 8 15 14 31
Fee income 4 9 6 23
Dividend and other income 2 12 11 24
From non-controlled/affiliated investments:
Interest income 2 8 3 16
Paid-in-kind interest income 13 18 25 36
Fee income 3
Dividend and other income 6 2 15
From controlled/affiliated investments:
Interest income 7 13 15 28
Paid-in-kind interest income 21 20 41 48
Fee income 1 1
Dividend and other income 66 73 133 133
Total investment income 290 398 594 798
Operating expenses
Management fees 44 53 92 105
Subordinated income incentive fees 23 36 48 75
Administrative services expenses 3 2 5 5
Accounting and administrative fees 1 1 2 2
Interest expense 101 125 206 238
Other general and administrative expenses 7 8 13 13
Total operating expenses 179 225 366 438
Subordinated income incentive fee waiver (11) (11)
Net expenses 168 225 355 438
Net investment income 122 173 239 360
Realized and unrealized gain/loss
Net realized gain (loss) on investments:
Non-controlled/unaffiliated investments (5) (66) (46) (106)
Non-controlled/affiliated investments (72) (1) (170) 8
Controlled/affiliated investments (68) (56) (55)
Net realized gain (loss) on foreign currency forward contracts (3) (4) (3)
Net realized gain (loss) on foreign currency (4) (6) (9) (5)
Net change in unrealized appreciation (depreciation) on investments:
Non-controlled/unaffiliated investments (47) 58 (286) 116
Non-controlled/affiliated investments 85 (62) 95 (82)
Controlled/affiliated investments (116) (151) (264) (203)
Net change in unrealized appreciation (depreciation) on foreign currency forward contracts (1) (10) 8 (20)
Net change in unrealized gain (loss) on foreign currency 6 (59) 20 (85)
Total net realized and unrealized gain (loss) (154) (368) (712) (435)
Provision for taxes on investments (11) (11)
Realized loss on extinguishment of debt (2) (3) (2) (3)
Net increase (decrease) in net assets resulting from operations (34) (209) (475) (89)

Consolidated Balance Sheets (Unaudited)

Description June 30, 2026 (Unaudited) December 31, 2025
Assets
Investments, at fair value
Non-controlled/unaffiliated investments (amortized cost—$7,393 and $8,406, respectively) 6,864 8,164
Non-controlled/affiliated investments (amortized cost—$743 and $929, respectively) 765 855
Controlled/affiliated investments (amortized cost—$4,469 and $4,406, respectively) 3,789 3,990
Total investments, at fair value (amortized cost—$12,605 and $13,741, respectively) 11,418 13,009
Cash and cash equivalents 107 181
Foreign currency, at fair value (cost—$2 and $27, respectively) 2 27
Receivable for investments sold and repaid 310 313
Income receivable 89 98
Unrealized appreciation on foreign currency forward contracts 1
Deferred financing costs 31 32
Prepaid expenses and other assets 36 69
Total assets 11,994 13,729
Liabilities
Payable for investments purchased 1 8
Debt (net of deferred financing costs and discount of $50 and $45, respectively) 6,471 7,634
Unrealized depreciation on foreign currency forward contracts 3 10
Stockholder distributions payable 118
Management fees payable 44 50
Subordinated income incentive fees payable 12 28
Administrative services expense payable 3 1
Interest payable 61 77
Other accrued expenses and liabilities 13 72
Total liabilities 6,726 7,880
Commitments and contingencies (Note 10)
Preferred stock, $0.001 par value per share, 50,000,000 shares authorized, respectively; 6,000,000 and 0 Cumulative Convertible Perpetual Preferred Stock, Series A shares, $0.001 par value per share, $25.00 liquidation preference per share, issued and outstanding, respectively 150
Stockholders’ equity
Common stock, $0.001 par value per share, 750,000,000 shares authorized, respectively, 279,688,633 and 280,066,433 shares issued and outstanding, respectively 0 0
Capital in excess of par value 9,195 9,199
Retained earnings (accumulated deficit) (4,077) (3,350)
Total stockholders’ equity 5,118 5,849
Total liabilities, preferred stock and stockholders’ equity 11,994 13,729
Net asset value per share of common stock at period end 18.30 20.89

Consolidated Statements of Cash Flows (Unaudited)

Description Six months ended June 30, 2026 Six months ended June 30, 2025
Cash flows from operating activities
Net increase (decrease) in net assets resulting from operations (475) (89)
Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities:
Purchases of investments (1,096) (3,104)
Paid-in-kind interest (80) (116)
Proceeds from sales and repayments of investments 2,047 2,763
Net realized (gain) loss on investments 272 153
Net change in unrealized (appreciation) depreciation on investments 455 169
Net change in unrealized (appreciation) depreciation on foreign currency forward contracts (8) 20
Realized loss on extinguishment of debt 2 3
Accretion of discount (11) (23)
Amortization of deferred financing costs and discount 9 11
Net change in unrealized (appreciation) depreciation on foreign currency translation (10) 108
(Increase) decrease in receivable for investments sold and repaid (134)
(Increase) decrease in income receivable 9 (7)
(Increase) decrease in prepaid expenses and other assets 4 (16)
Increase (decrease) in payable for investments purchased 1
Increase (decrease) in management fees payable (6)
Increase (decrease) in subordinated income incentive fees payable (16) 1
Increase (decrease) in administrative services expense payable 2 3
Increase (decrease) in interest payable (16) (28)
Increase (decrease) in other accrued expenses and liabilities (61) (25)
Net cash provided by (used in) operating activities 1,021 (310)
Cash flows from financing activities
Issuance of Cumulative Convertible Perpetual Preferred Stock, Series A 150
Repurchases of common stock (2)
Distributions to common stockholders (134) (196)
Borrowings under financing arrangements 2,481 5,500
Repayments of financing arrangements (3,600) (4,971)
Deferred financing costs paid (15) (7)
Net cash provided by (used in) financing activities (1,120) 326
Effect of exchange rate changes on cash
Total increase (decrease) in cash, cash equivalents, restricted cash and foreign currency (99) 16
Cash, cash equivalents, restricted cash and foreign currency at beginning of period 208 296
Cash, cash equivalents, restricted cash and foreign currency at end of period(1) 109 312
Supplemental information
Federal income taxes paid during the period 0 7
Interest paid during the period 213 255

Amounts as printed on the EDGAR/iXBRL face. Labels, columns, and figures are the filing face, not a GAAP stencil. Interactive statements & notes on EDGAR ↗

View AI report for this filing